DMK Pharmaceuticals Corp
DMKDelisted Mar 21, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000887247
DMK Pharmaceuticals Corp was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Nov 2, 2023; 29 institutions reported holding it in 13F filings for Q4 2023, worth $350.4K in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding DMK Pharmaceuticals Corp changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 46 | 45 | −1 |
| Shares | 12.9M | 12.9M | −60.9K (−0.5%) |
| Value | $7.38M | $6.44M | −$934.0K (−12.7%) |
New holders (5)
Institutions that held DMK Pharmaceuticals Corp at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 93,669 | $47.0K | 0.01% |
| HRT Financial LP | 27,235 | $13.0K | 0.00% |
| Jane Street Group, LLC | 17,422 | $9.00K | 0.00% |
| Harbour Investments, Inc. | 12,860 | $6.00K | 0.00% |
| Investors Asset Management of Georgia Inc | 100 | $0 | 0.00% |
Sold out (6)
Institutions that held DMK Pharmaceuticals Corp at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Susquehanna International Group, LLP | 173,979 | $99.0K |
| Citadel Advisors LLC | 48,048 | $27.0K |
| Principal Financial Group Inc | 16,872 | $10.0K |
| Goldman Sachs Group Inc | 12,615 | $7.00K |
| Royal Bank of Canada | 5,000 | $3.00K |
| Citigroup Inc | 250 | $0 |